KZA 0.00% 39.0¢ kazia therapeutics limited

phase ii : are the results good enough to pass?

  1. 57 Posts.
    Is 20-30 % response rate for the ovarian cancer trials in Yale good enough to proceed to Phase III?

    Surely this would be be their major short medium term hurdle.

    Interested in your opinions on this.

    I hold NRT
 
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.